RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Astec Lifesciences Stock

Astec Lifesciences ROA 2024

Astec Lifesciences ROA

-0.05

Ticker

ASTEC.NS

ISIN

INE563J01010

In 2024, Astec Lifesciences's return on assets (ROA) was -0.05, a -148.04% increase from the 0.1 ROA in the previous year.

Astec Lifesciences Aktienanalyse

What does Astec Lifesciences do?

Astec Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Astec Lifesciences's Return on Assets (ROA)

Astec Lifesciences's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Astec Lifesciences's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Astec Lifesciences's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Astec Lifesciences’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Astec Lifesciences stock

What is the Return on Assets (ROA) of Astec Lifesciences this year?

The Return on Assets (ROA) of Astec Lifesciences is -0.05 undefined this year.

What was the ROA of Astec Lifesciences compared to the previous year?

The ROA of Astec Lifesciences has increased by -148.04% compared to the previous year.

What consequences do high ROA have for investors of Astec Lifesciences?

A high ROA is advantageous for investors of Astec Lifesciences, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Astec Lifesciences?

A low ROA can be unfavorable for investors of Astec Lifesciences as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Astec Lifesciences affect the company?

An increase in ROA of Astec Lifesciences can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Astec Lifesciences impact the company?

A reduction in the ROA of Astec Lifesciences can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Astec Lifesciences?

Some factors that can influence the ROA of Astec Lifesciences include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Astec Lifesciences important for investors?

The ROA of Astec Lifesciences is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Astec Lifesciences take to improve ROA?

To improve ROA, Astec Lifesciences can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Astec Lifesciences pay?

Over the past 12 months, Astec Lifesciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Astec Lifesciences is expected to pay a dividend of 0.34 INR.

What is the dividend yield of Astec Lifesciences?

The current dividend yield of Astec Lifesciences is .

When does Astec Lifesciences pay dividends?

Astec Lifesciences pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of Astec Lifesciences?

Astec Lifesciences paid dividends every year for the past 3 years.

What is the dividend of Astec Lifesciences?

For the upcoming 12 months, dividends amounting to 0.34 INR are expected. This corresponds to a dividend yield of 0.03 %.

In which sector is Astec Lifesciences located?

Astec Lifesciences is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Astec Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Astec Lifesciences from 8/1/2023 amounting to 1.5 INR, you needed to have the stock in your portfolio before the ex-date on 7/21/2023.

When did Astec Lifesciences pay the last dividend?

The last dividend was paid out on 8/1/2023.

What was the dividend of Astec Lifesciences in the year 2023?

In the year 2023, Astec Lifesciences distributed 1.5 INR as dividends.

In which currency does Astec Lifesciences pay out the dividend?

The dividends of Astec Lifesciences are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Astec Lifesciences

Our stock analysis for Astec Lifesciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Astec Lifesciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.